ZNTL (Zentalis Pharmaceuticals Inc) stock is currently covered by 6 analysts. The average analyst rating is 4.8 out of 5.
ZNTL analysts have given it a high price target of $75, mean price target of $66.4, and a low price target of $63.
ZNTL currently has an estimated 12-Month price forecast of $66.4 based on the average analyst price target.
[wpdatatable id=10 var1=ZNTL]